Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Brickell Biotech Inc (BBI)

0.8369   0.009 (1.1%) 08-14 16:00
Open: 0.83 Pre. Close: 0.8278
High: 0.8537 Low: 0.8276
Volume: 281,671 Market Cap: 23M
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead products candidate is sofpironium bromide that is in Phase III clinical trial for patients with axillary hyperhidrosis. It is also developing therapeutics for cutaneous T-cell lymphoma, psoriasis, and other dermatological conditions. The company was founded in 2009 and is based in Boulder, Colorado.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.851 - 0.855 0.855 - 0.858
Low: 0.82 - 0.825 0.825 - 0.829
Close: 0.833 - 0.84 0.84 - 0.847

Technical analysis

as of: 2020-08-14 4:27:40 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.04     One year: 1.17
Support: Support1: 0.71    Support2: 0.59
Resistance: Resistance1: 0.89    Resistance2:
Pivot: 0.91
Moving Average: MA(5): 0.87     MA(20): 0.91
MA(100): 1.10     MA(250): 2.06
MACD: MACD(12,26): -0.04     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 17.57     %D(3): 21.91
RSI: RSI(14): 37.11
52-week: High: 6.51  Low: 0.71  Change(%): -85.9
Average Vol(K): 3-Month: 188060  10-Days: 51339

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BBI has closed above bottom band by 0.3%. Bollinger Bands are 67.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to BBI's normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Aug 2020
The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller - Benzinga

Wed, 12 Aug 2020
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 03 Aug 2020
Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020 - Yahoo Finance

Fri, 31 Jul 2020
Brickell Biotech, Inc. (NASDAQ:BBI) down -6% over the past 30 days: Any Troubles Ahead? - Marketing Sentinel

Fri, 31 Jul 2020
Boiling and ready to burst as Brickell Biotech Inc. (BBI) last month performance was -6.00% - The InvestChronicle

Tue, 28 Jul 2020
Will current price volatility hamper Brickell Biotech, Inc. (BBI) future potential? - Marketing Sentinel

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 9
% Held by Insiders 14.31
% Held by Institutions 31.99
Shares Short (K) 134
Shares Short P. Month (K) 63

Stock Financials

EPS -3.167
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.330
Profit Margin
Operating Margin -428.06
Return on Assets (ttm) -170.8
Return on Equity (ttm)
Qtrly Rev. Growth -70.0
Gross Profit (p.s.) -0.503
Sales Per Share 0.224
EBITDA (p.s.) -0.957
Qtrly Earnings Growth
Operating Cash Flow (M) -37
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -0.26
PEG Ratio
Price to Book value 0.36
Price to Sales 3.74
Price to Cash Flow -0.55

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.